Search Within

Kevin Joseph Curran

  1. "Ann Jakubowski"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Biostatistics Service (11)
  2. Bone Marrow Transplant (11)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. Epidemiology and Biostatistics (11)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Ann Jakubowski (11)
  2. Sergio Giralt (11)
  3. Esperanza Papadopoulos (10)
  4. Miguel-Angel Perales (10)
  5. Richard O'Reilly (10)
  6. Nancy Kernan (9)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (1)
  5. 2020 (3)
  6. 2015 (1)

More Years

Publications
  1. Blood Advances (3)
  2. Blood (2)
  3. Bone Marrow Transplantation (2)
  4. Journal of Clinical Investigation (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Cytotherapy (1)
Publishers
  1. American Society of Hematology (5)
  2. American Society for Clinical Investigation (2)
  3. Nature Publishing Group (2)
  4. Elsevier Inc. (1)
  5. Elsevier Science Ltd. (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of B cell immune reconstituion on non-relapse mortality in T cell depleted allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lucas, A. T.; Scordo, M.; Lakkaraja, M.; White, C.; Mauguen, A.; Shaffer, B.; Jakubowski, A.; Cho, C.; Gyurkocza, B.; Papadopoulos, E.; more...
    Cytotherapy (2025)

    Fulltext@MSK | Save
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Phase II study of pharmacokinetic model-based ATG dosing to improve survival through enhanced immune reconstitution in patients undergoing ex vivo CD34-selected allogeneic HCT (PRAISE-IR)
    Meeting Abstract

    Scordo, M.; Perales, M. A.; Mauguen, A.; Lin, A.; Kunvarjee, B.; Bieler, J.; Nguyen, L. K.; Paes Pena, M.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save